2009
DOI: 10.1111/j.1526-4637.2009.00662.x
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of a Metered-dose 8% Lidocaine Pump Spray for Patients with Post-herpetic Neuralgia

Abstract: In both studies, XPS provided a significant improvement in PHN due to its prompt analgesia, lack of systemic side effects, and convenience of use.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
8
1
1

Relationship

2
8

Authors

Journals

citations
Cited by 22 publications
(18 citation statements)
references
References 19 publications
0
14
0
Order By: Relevance
“…A difference of 3 cm of VAS score was considered clinically significant [17]. Based on a preliminary examination, we estimated the within-group standard deviation for VAS score of 2.5 cm.…”
Section: Discussionmentioning
confidence: 99%
“…A difference of 3 cm of VAS score was considered clinically significant [17]. Based on a preliminary examination, we estimated the within-group standard deviation for VAS score of 2.5 cm.…”
Section: Discussionmentioning
confidence: 99%
“…[119] Lidocaine has also been used as a topical spray for dressing changes, for pain associated with peripheral blood flow disorders, and post herpetic neuralgia. [121][122][123] Safety issues have been considered in a 2002 pharmacokinetic study that considered the 5% lidocaine patch to be safe, only causing mild skin erythema and low plasma lidocaine levels [124], but a single case report has concluded that lidocaine toxicity is possible when multiple forms of topical application are used. [125] Topical non-steroidal anti-inflammatory drugs (NSAIDs): Extracts from willow trees and other salicylate containing plants also have their origins in antiquity, possibly dating back to the Sumerians and ancient Egyptians in the treatment of fevers.…”
Section: Facit Ad Maximos Dolores -Useful For Extreme Painmentioning
confidence: 99%
“…A metered‐dose pump of 8% lidocaine (LDC; Xylocaine pump spray ® , Astra Zeneca, Osaka, Japan) is commercially available and mainly used for anesthetizing mucosal membranes, e.g., preparation of the upper airway for endoscopy. This preparation includes flavor and fragrance, and can be easily used for intraoral applications [6,7]. To test our hypothesis, we examined in a double‐blind, placebo ( PBO )‐controlled crossover study the efficacy of intraoral LDC in the relief of oral pain in patients with TN.…”
Section: Introductionmentioning
confidence: 99%